Sign Up to like & get
recommendations!
1
Published in 2018 at "Contemporary Clinical Trials Communications"
DOI: 10.1016/j.conctc.2018.08.010
Abstract: To evaluate the overall success rate of a new drug, phase 1, 2, and 3 trials were simulated using eight toxicity and two non-decreasing efficacy profiles. Six phase 1 designs including the standard 3 +…
read more here.
Keywords:
phase;
overall success;
toxicity;
phase designs ... See more keywords